These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21945823)

  • 1. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
    Roxburgh CS; McMillan DC
    Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical utility of the local inflammatory response in colorectal cancer.
    Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.
    Curtis NJ; Primrose JN; Thomas GJ; Mirnezami AH; Ottensmeier CH
    Eur J Surg Oncol; 2012 Oct; 38(10):889-96. PubMed ID: 22721580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
    Galon J; Costes A; Sanchez-Cabo F; Kirilovsky A; Mlecnik B; Lagorce-Pagès C; Tosolini M; Camus M; Berger A; Wind P; Zinzindohoué F; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Pagès F
    Science; 2006 Sep; 313(5795):1960-4. PubMed ID: 17008531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response.
    Ong SM; Tan YC; Beretta O; Jiang D; Yeap WH; Tai JJ; Wong WC; Yang H; Schwarz H; Lim KH; Koh PK; Ling KL; Wong SC
    Eur J Immunol; 2012 Jan; 42(1):89-100. PubMed ID: 22009685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Eur J Cancer; 2009 Aug; 45(12):2138-45. PubMed ID: 19409772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
    Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
    Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
    Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
    Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.
    Canna K; McArdle PA; McMillan DC; McNicol AM; Smith GW; McKee RF; McArdle CS
    Br J Cancer; 2005 Feb; 92(4):651-4. PubMed ID: 15700032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy.
    Maby P; Tougeron D; Hamieh M; Mlecnik B; Kora H; Bindea G; Angell HK; Fredriksen T; Elie N; Fauquembergue E; Drouet A; Leprince J; Benichou J; Mauillon J; Le Pessot F; Sesboüé R; Tuech JJ; Sabourin JC; Michel P; Frébourg T; Galon J; Latouche JB
    Cancer Res; 2015 Sep; 75(17):3446-55. PubMed ID: 26060019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
    Pagès F; Kirilovsky A; Mlecnik B; Asslaber M; Tosolini M; Bindea G; Lagorce C; Wind P; Marliot F; Bruneval P; Zatloukal K; Trajanoski Z; Berger A; Fridman WH; Galon J
    J Clin Oncol; 2009 Dec; 27(35):5944-51. PubMed ID: 19858404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
    Talmadge JE; Donkor M; Scholar E
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
    Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
    Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordination of intratumoral immune reaction and human colorectal cancer recurrence.
    Camus M; Tosolini M; Mlecnik B; Pagès F; Kirilovsky A; Berger A; Costes A; Bindea G; Charoentong P; Bruneval P; Trajanoski Z; Fridman WH; Galon J
    Cancer Res; 2009 Mar; 69(6):2685-93. PubMed ID: 19258510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.